GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rockwell Medical Inc (NAS:RMTI) » Definitions » Piotroski F-Score

Rockwell Medical (Rockwell Medical) Piotroski F-Score : 4 (As of Apr. 26, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Rockwell Medical Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Rockwell Medical has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Rockwell Medical's Piotroski F-Score or its related term are showing as below:

RMTI' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 3   Max: 6
Current: 4

During the past 13 years, the highest Piotroski F-Score of Rockwell Medical was 6. The lowest was 2. And the median was 3.


Rockwell Medical Piotroski F-Score Historical Data

The historical data trend for Rockwell Medical's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rockwell Medical Piotroski F-Score Chart

Rockwell Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 3.00 2.00 6.00 4.00

Rockwell Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 6.00 5.00 4.00 4.00

Competitive Comparison of Rockwell Medical's Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rockwell Medical's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Rockwell Medical's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -1.75 + -3.305 + -1.872 + -1.512 = $-8.44 Mil.
Cash Flow from Operations was -3.876 + -1.74 + -3.753 + -0.043 = $-9.41 Mil.
Revenue was 19.668 + 18.08 + 23.771 + 22.093 = $83.61 Mil.
Gross Profit was 2.599 + 1.033 + 2.202 + 2.87 = $8.70 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(46.635 + 40.472 + 38.037 + 52.606 + 52.173) / 5 = $45.9846 Mil.
Total Assets at the begining of this year (Dec22) was $46.64 Mil.
Long-Term Debt & Capital Lease Obligation was $11.26 Mil.
Total Current Assets was $28.77 Mil.
Total Current Liabilities was $16.64 Mil.
Net Income was -7.162 + -4.967 + -4.19 + -2.362 = $-18.68 Mil.

Revenue was 16.124 + 18.682 + 18.691 + 19.313 = $72.81 Mil.
Gross Profit was -0.786 + 1.745 + 0.777 + 2.34 = $4.08 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(48.574 + 37.436 + 59.116 + 54.186 + 46.635) / 5 = $49.1894 Mil.
Total Assets at the begining of last year (Dec21) was $48.57 Mil.
Long-Term Debt & Capital Lease Obligation was $12.22 Mil.
Total Current Assets was $35.31 Mil.
Total Current Liabilities was $17.69 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Rockwell Medical's current Net Income (TTM) was -8.44. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Rockwell Medical's current Cash Flow from Operations (TTM) was -9.41. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-8.439/46.635
=-0.18095851

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-18.681/48.574
=-0.38458846

Rockwell Medical's return on assets of this year was -0.18095851. Rockwell Medical's return on assets of last year was -0.38458846. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Rockwell Medical's current Net Income (TTM) was -8.44. Rockwell Medical's current Cash Flow from Operations (TTM) was -9.41. ==> -9.41 <= -8.44 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=11.256/45.9846
=0.2447776

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=12.224/49.1894
=0.24850883

Rockwell Medical's gearing of this year was 0.2447776. Rockwell Medical's gearing of last year was 0.24850883. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=28.77/16.637
=1.72927812

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=35.31/17.691
=1.99593013

Rockwell Medical's current ratio of this year was 1.72927812. Rockwell Medical's current ratio of last year was 1.99593013. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Rockwell Medical's number of shares in issue this year was 28.711. Rockwell Medical's number of shares in issue last year was 18.509. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=8.704/83.612
=0.10409989

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=4.076/72.81
=0.05598132

Rockwell Medical's gross margin of this year was 0.10409989. Rockwell Medical's gross margin of last year was 0.05598132. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=83.612/46.635
=1.79290233

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=72.81/48.574
=1.49895006

Rockwell Medical's asset turnover of this year was 1.79290233. Rockwell Medical's asset turnover of last year was 1.49895006. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+0+1+0+0+1+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Rockwell Medical has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Rockwell Medical  (NAS:RMTI) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Rockwell Medical Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Rockwell Medical's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Rockwell Medical (Rockwell Medical) Business Description

Traded in Other Exchanges
Address
30142 S. Wixom Road, Wixom, MI, USA, 48393
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. Rockwell Medical's mission is to provide dialysis clinics and patients with the highest quality products supported by the best customer service in the industry. It is focused on innovative, long-term growth strategies that enhance products, processes, and people, enabling the company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients.
Executives
Jesse Neri officer: SVP, FINANCE 851 DUPORTAIL ROAD, SECOND FLOOR, CHESTERBROOK PA 19087
Joan Lau director C/O RENOVACOR, INC., 5 MEAD POINT DRIVE, GREENWICH CT 06830
Russell Skibsted officer: See Remarks 15 TRANQUILITY PLACE, LADERA RANCH CA 92694
Megan C. Timmins officer: SVP, General Counsel 600 LEE ROAD, SUITE 100, WAYNE PA 19087
Mark Strobeck director, officer: President and CEO 460 EAST SWEDESFORD ROAD, SUITE 1050, WAYNE PA 19087
Allen Nissenson director 601 HAWAII ST., EL SEGUNDO CA 90245
Robert S Radie director 101 LINDENWOOD DRIVE, SUITE 225, MALVERN PA 19355
Andrea Heslin Smiley director 600 LEE ROAD, SUITE 100, WAYNE PA 19087
David S. Richmond 10 percent owner, other: See Footnote 1 3568 WILDWOOD AVENUE, JACKSON MI 49202
Russell H Ellison director 270 RIVERSIDE DR., APT. 12D, NEW YORK NY 10025
Marc L Hoffman officer: Chief Medical Officer 30142 WIXOM ROAD, WIXOM MI 48393
John Peter Mclaughlin director C/O PDL BIOPHARMA, INC., 932 SOUTHWOOD BOULEVARD, INCLINE VILLAGE NV 89451
Richmond Brothers, Inc. 10 percent owner, other: See Footnote 1 7415 FOXWORTH COURT, JACKSON MI 49201
Stuart M Paul director, officer: Chief Executive Officer HOME DIAGNOSTICS, INC., 2400 NW 55TH COURT, FORT LAUDERDALE FL 33309
Angus W. Smith officer: Chief Financial Officer C/O PERNIX THERAPEUTICS HOLDINGS, INC., 10 NORTH PARK PLACE, SUITE 201, MORRISTOWN NJ 07960